Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE:524558

₹7702.00 54.65 (0.71%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

7563.00

Today’s High

7790.00

52W low

2786.10

52W High

8079.00

Open Price

7647.00

Prev. Close

6160.3500

Volume

21215.00

Value

163397930.00

Fundamentals

Market Cap Cr

9881.60

Price to Earnings

32.90

Price to Book Value

7.70

Dividend Yield

0.10

PE to Growth

0.40

Op Revenue TTM Cr

1558.58

Net Profit TTM Cr

300.08

Cash From Operating Activity Cr

261.18

Return on Equity %

23.39

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

7596.4

10Day EMA

7378.2

12Day EMA

7298.8

20Day EMA

7069.1

26Day EMA

6967.8

50Day EMA

6785

100Day EMA

6508

200Day EMA

5790.8

5Day SMA

7637.4

10Day SMA

7360.5

20Day SMA

6890.7

30Day SMA

6653.1

50Day SMA

6743

100Day SMA

6707.6

150Day SMA

6318.5

200Day SMA

5791.3

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

04 Jul, 2024

38.6

Week

53.8

Month

60.7

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

7685.00

PIVOT

First Resistance

7807.00

Second Resistance

7912.00

Third Resistance

8034.00

First Support

7580.00

Second Support

7458.00

Third Support

7353.00

Relative Strength Index

72.23

Money Flow Index

76.7

MACD

331.05

MACD Signal

218.68

Average True Range

336.67

Average Directional Index

32.52

Rate of Change (21)

27.38

Rate of Change (125)

40.63

Commodity Channel Index

101.4

Williams %R

-22.2

BETA

1 Month

0.53

3 Month

0.2

1 Year

0.63

3 Year

0.22

PRICE CHANGE ANALYSIS

↑ 5.97%

1 Week

Low

High

7210.8

8079

↑ 25.96%

1 Month

Low

High

5540.1

8079

↑ 19.12%

3 Months

Low

High

5540.1

8079

↑ 37.73%

6 Months

Low

High

5021.1

8079

↑ 171.53%

1 Year

Low

High

2786.1

8079

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 390.37 394.93 420.80 365.03 415.14 270.18 293.94 221.68 256.50 238.37 258.13
Operating Expenses Qtr 278.21 272.26 280.45 265.73 287.36 215.31 224.54 192.69 217.16 204.18 215.06
Operating Profit Qtr 106.79 120.56 137.30 97.26 119.72 53.94 69.17 28.48 38.71 32.29 42.79
EBIDT Qtr Cr 112.15 122.66 140.35 99.30 127.78 54.88 69.41 28.99 39.34 34.19 43.08
Depreciation Qtr 16.46 15.14 14.51 13.59 13.47 13.34 13.17 12.80 12.45 12.77 11.98
Net Profit Qtr 67.61 80.70 89.06 62.22 84.51 30.44 38.33 9.84 21.83 12.73 20.33
Basic EPS Qtr 52.70 62.90 69.42 48.50 65.87 23.72 29.88 7.67 17.01 9.92 15.84
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 1571.12 1200.95 953.15 953.01 766.60
Operating Expenses Annual Cr 1096.66 919.89 808.88 790.47 661.25
Operating Profit Annual 461.92 271.31 142.19 146.44 101.46
Operating Profit Margin Annual % 29.40 22.59 14.92 15.37 13.23
Total Expenses Annual Cr 1170.36 985.73 871.41 848.05 714.10
EBIDT Annual Cr 474.47 281.06 144.27 162.54 105.34
EBIDT Annual margin % 30.20 23.40 15.14 17.06 13.74
Depreciation 59.70 52.78 49.04 39.68 31.28
PAT Before ExtraOrdinary Items Annual Cr 299.60 163.12 63.53 80.29 15.88
Net Profit Annual 299.60 163.12 63.53 80.29 15.88
Basic EPS Annual 233.51 127.14 49.52 62.58 12.38
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 1276.54 988.36 835.57 781.88 705.55
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 120.59 145.22 178.42 168.68 162.21
Total Current Liabilities Annual Cr 433.80 445.75 368.13 372.96 361.99
Total Capital Plus Liabilities Annual Cr 1830.93 1579.34 1382.12 1323.52 1229.74
Fixed Assets Annual 869.55 798.10 787.82 733.08 676.32
Total Non Current Assets Annual 911.46 819.00 800.89 775.34 715.91
Total Current Assets Annual 919.47 760.34 581.23 548.18 513.83
Total Assets Annual 1830.93 1579.34 1382.12 1323.52 1229.74
Contingent Liabilities plus Commitments Annual Cr - 100.72 92.99 127.52 134.68
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 260.06 238.53 58.60 189.28 56.63
Cash from Investing Activity Annual -149.67 -61.50 -93.72 -84.42 -48.68
Cash from Financing Annual Activity -69.28 -135.80 37.72 -113.66 -5.48
Net Cash Flow Annual - 41.24 2.60 -8.80 2.47
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 989.53 765.49 647.06 605.43 546.26
ROE Annual % 23.46 16.51 7.61 10.28 2.25
ROCE Annual % 29.68 20.13 9.39 12.92 8.53
Total Debt to Total Equity Annual 0.06 0.12 0.28 0.19 0.35
EBDIT Annual Margin % 30.44 23.59 15.16 17.34 13.81
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 390.37 394.93 420.80 365.03 415.14 270.18 293.94 221.68 256.50 238.37 258.13
Operating Expenses Qtr 278.09 271.56 280.26 266.07 287.21 215.17 224.41 192.57 217.00 204.04 215.01
Operating Profit Qtr 106.92 121.27 137.49 96.92 119.86 54.08 69.30 28.60 38.87 32.43 42.83
EBIDT Qtr Cr 112.27 123.37 140.53 98.96 127.92 55.02 69.54 29.12 39.50 34.33 43.12
Depreciation Qtr 16.46 15.14 14.51 13.59 13.47 13.34 13.17 12.80 12.45 12.77 11.98
Net Profit Qtr 67.56 81.39 89.25 61.88 84.54 30.55 38.46 9.97 21.78 12.94 20.37
Basic EPS Qtr 52.66 63.44 69.56 48.23 65.90 23.81 29.97 7.77 16.97 10.08 15.88
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 1571.12 1200.95 953.15 953.01 766.60
Operating Expenses Annual Cr 1095.99 919.36 808.46 790.09 660.82
Operating Profit Annual 462.59 271.84 142.62 146.82 101.89
Operating Profit Margin Annual % 29.44 22.64 14.96 15.41 13.29
Total Expenses Annual Cr 1169.69 985.20 870.99 847.67 713.67
EBIDT Annual Cr 475.13 281.59 144.70 162.91 105.78
EBIDT Annual margin % 30.24 23.45 15.18 17.09 13.80
Depreciation 59.70 52.78 49.04 39.68 31.28
PAT Before ExtraOrdinary Items Annual Cr 300.08 163.52 63.82 80.63 16.21
Net Profit Annual 300.08 163.52 63.82 80.63 16.21
Basic EPS Annual 233.89 127.45 49.74 62.85 12.63
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 1282.70 994.10 840.50 786.46 709.96
Minority Interest Liability Annual Cr 0.00 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 122.17 146.71 179.83 169.82 163.39
Total Current Liabilities Annual Cr 427.68 438.96 363.16 368.51 357.63
Total Capital Plus Liabilities Annual Cr 1832.56 1579.76 1383.49 1324.79 1230.98
Fixed Assets Annual 590.10 518.64 508.35 453.63 396.86
Total Non Current Assets Annual 911.48 818.87 800.71 775.20 715.79
Total Current Assets Annual 921.08 760.89 582.78 549.59 515.19
Total Assets Annual 1832.56 1579.76 1383.49 1324.79 1230.98
Contingent Liabilities plus Commitments Annual Cr - 100.72 92.99 127.52 134.68
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 261.18 237.21 58.58 189.36 57.34
Cash from Investing Activity Annual -149.69 -61.50 -93.71 -84.42 -48.68
Cash from Financing Annual Activity -69.28 -135.80 37.72 -113.66 -5.48
Net Cash Flow Annual - 39.92 2.59 -8.72 3.18
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 994.31 769.94 650.88 608.98 549.68
ROE Annual % 23.39 16.46 7.60 10.26 2.28
ROCE Annual % 29.57 20.05 9.37 12.88 8.52
Total Debt to Total Equity Annual 0.06 0.12 0.28 0.18 0.35
EBDIT Annual Margin % 30.48 23.63 15.21 17.38 13.86
Name Holding Percent Holding Id Pledged % Locked %
MALABAR INDIA FUND LIMITED 9.95 74517945 - -
MATTHEWS INDIA FUND 2.11 74517946 - -
KEDIA SECURITIES PRIVATE LIMITED 1.09 74517953 - -
MUKUL MAHAVIR AGRAWAL 3.12 74517956 - -
Name Holding Percent Holding Id Pledged % Locked %
RAMAMOHAN RAO DAVULURI 21.59 74517928 0 0
DAVULURI VIJAYA RAO 4.78 74517929 0 0
DAVULURI SUCHETH RAO 2.63 74517930 0 0
DAVULURI SAHARSH RAO 2.24 74517931 0 0
DAVULURI ROHINI NIVEDITHA RAO 0.67 74517932 0 0
Name Holding Percent Holding Id
HSBC MULTI CAP FUND 2.6 74517942
MALABAR INDIA FUND LIMITED 9.95 74517945
MATTHEWS INDIA FUND 2.11 74517946
Name Holding Percent Holding Id
MUKUL MAHAVIR AGRAWAL 3.12 74517956
SIDDHARTH IYER 1.45 74517957
HUF 0.8 74517949
KEDIA SECURITIES PRIVATE LIMITED 1.09 74517953
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Jul 11, 2023 10 FINAL - Equity Share
Jul 14, 2022 5 FINAL Jul 15, 2022 Equity Share
Jun 29, 2021 3 FINAL - Equity Share
Nov 10, 2020 2 INTERIM Nov 11, 2020 Equity Share
Feb 18, 2020 2 INTERIM Feb 20, 2020 Equity Share
Jun 27, 2019 1.2 FINAL - Equity Share
Aug 04, 2016 2 FINAL - Equity Share
Aug 06, 2015 1.5 FINAL - Equity Share
Jun 16, 2014 1.5 SPECIAL - Equity Share
Jun 16, 2014 1.5 FINAL - Equity Share
Jul 24, 2013 1.2 FINAL - Equity Share
Jul 13, 2009 3.5 FINAL - Equity Share
Jul 17, 2008 2.5 FINAL - Equity Share
Jul 11, 2007 2.5 FINAL - Equity Share
Aug 01, 2006 2 FINAL - Equity Share
Jul 20, 2005 1.2 FINAL - Equity Share
Jul 18, 2003 1 FINAL - Equity Share
Jul 11, 2002 - FINAL - Equity Share
Jun 27, 2001 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 10, 2024 Audited Results & Final Dividend -
Feb 08, 2024 Quarterly Results -
Nov 07, 2023 Quarterly Results -
Aug 03, 2023 Quarterly Results -
May 11, 2023 Audited Results & Final Dividend -
Feb 13, 2023 Quarterly Results -
Nov 10, 2022 Quarterly Results -
Aug 03, 2022 Quarterly Results -
May 10, 2022 Audited Results & Final Dividend -
Feb 01, 2022 Quarterly Results -
Oct 29, 2021 Quarterly Results -
Aug 03, 2021 Quarterly Results -
May 11, 2021 Audited Results & Final Dividend -
Feb 02, 2021 Quarterly Results (Revised)
Nov 03, 2020 Quarterly Results & Interim Dividend -
Aug 04, 2020 Quarterly Results -
May 22, 2020 Audited Results -
Feb 11, 2020 Quarterly Results & Interim Dividend -
Nov 14, 2019 Quarterly Results -
Aug 13, 2019 Quarterly Results -
May 16, 2019 Audited Results & Dividend -
Feb 12, 2019 Quarterly Results -
Nov 02, 2018 Quarterly Results -
Aug 10, 2018 Quarterly Results -
May 11, 2018 Audited Results -
Apr 09, 2018 To consider raising of funds inter alia, to consider a proposal for raising funds by way of issuance of equity shares or equity linked securities such as warrants or convertible securities.
Feb 02, 2018 Quarterly Results -
Nov 22, 2017 Quarterly Results -
Sep 11, 2017 Quarterly Results -
May 12, 2017 Audited Results -
Feb 10, 2017 Quarterly Results -
Nov 04, 2016 Quarterly Results -
Aug 27, 2016 Scheme of Amalgamation -
Aug 12, 2016 Quarterly Results -
May 20, 2016 Audited Results & Dividend 1. Re-designation of Mr. D. Sucheth Rao as. Vice Chairman & Chief Executive Officer, subject to the approval of the members. 2. Re-designation of Mr. D. Saharsh Rao as Joint Managing Director.
Feb 03, 2016 Quarterly Results -
Oct 30, 2015 Others 1. Policy for preservation of documents under Regulation 9 of SEBI Listing Regulations, 2015. 2. Policy of determination of materiality of Events or Information under Regulation 30 of SEBI.
Oct 29, 2015 Quarterly Results -
Aug 14, 2015 Quarterly Results -
May 08, 2015 Audited Results & Dividend Appointed Dr. Nirmala Murthy as an Additional Director & reappointment of Mr. D. Saharsh Rao as Whole time Director of the Company.
Jan 30, 2015 Quarterly Results -
Oct 29, 2014 Quarterly Results -
Aug 01, 2014 Quarterly Results -
May 09, 2014 Audited Results & Dividend -
Feb 05, 2014 Right Issue of Equity Shares -
Nov 08, 2013 Quarterly Results -
Aug 02, 2013 Quarterly Results -
May 10, 2013 Audited Results & Dividend -
Feb 13, 2013 Quarterly Results -
Nov 09, 2012 Quarterly Results -
Aug 10, 2012 Quarterly Results -
May 03, 2012 Audited Results -
Feb 10, 2012 Quarterly Results -
Nov 03, 2011 Quarterly Results -
Aug 05, 2011 Quarterly Results -
Jul 07, 2011 Right Issue of Equity Shares inter alia, to consider the issue of equity shares on rights issue basis to the members of the Company.
May 20, 2011 Audited Results & Dividend -
Feb 02, 2011 Quarterly Results -
Oct 29, 2010 Quarterly Results -
Jul 29, 2010 Quarterly Results -
May 29, 2010 Audited Results (Revised)
Jan 28, 2010 Quarterly Results -
Oct 20, 2009 Quarterly Results -
Jul 18, 2009 Quarterly Results -
May 21, 2009 Audited Results & Dividend -
Jan 22, 2009 Quarterly Results -
Oct 24, 2008 Quarterly Results -
Jul 24, 2008 Quarterly Results -
May 23, 2008 Audited Results -
Jan 25, 2008 Quarterly Results -
Oct 24, 2007 Quarterly Results -
Jul 20, 2007 Quarterly Results -
May 18, 2007 Audited Results & Dividend -
Jan 27, 2007 Quarterly Results -
Oct 30, 2006 Quarterly Results -
Jul 27, 2006 Quarterly Results -
Jun 22, 2006 Accounts & Dividend -
Jan 24, 2006 Quarterly Results & Others To consider re-issue of forfeited shares
Oct 25, 2005 Quarterly Results/Forfeiture of shares -
Jul 29, 2005 Quarterly Results -
Jun 13, 2005 Accounts & Dividend -
Jan 24, 2005 Quarterly Results -
Dec 17, 2004 Others Allotted 2,74,986 warrants convertible into equity shares @ Rs.10/-each at a premium of Rs.238.20 to the promoters Dr. D.R. Rao and M/s. Sucheth and Shah Holdings Private Ltd.
Nov 17, 2004 Half Yearly Results & Others To consider issue of share warrants to promoters on preferential basis.
Jul 28, 2004 Quarterly Results -
Jun 12, 2004 Accounts -
Apr 28, 2004 Quarterly Results -
Jan 31, 2004 Quarterly Results -
Oct 23, 2003 Quarterly Results -
Jul 29, 2003 Quarterly Results -
Jun 20, 2003 Accounts -
Jan 31, 2003 Quarterly Results -
Oct 31, 2002 Quarterly Results -
Jul 29, 2002 Quarterly Results -
Jan 25, 2002 Quarterly Results -
Oct 20, 2001 Half Yearly Results -
Jun 16, 2001 Accounts -
Jan 18, 2001 Quarterly Results -
Oct 31, 2000 Quarterly Results -
Jul 29, 2000 Quarterly Results -
May 18, 2000 Accounts -
Jan 28, 2000 Quarterly Results -
Oct 23, 1999 Accounts, Q.Results & Rights Issue -
Oct 22, 1999 Accounts & Quarterly Results -
Jul 24, 1999 Quarterly Results -
Apr 30, 1999 Quarterly Results -
Jan 25, 1999 Quarterly Results -
Oct 29, 1998 Half Yearly Results -
Jun 30, 1998 Accounts & Dividend -
Nov 29, 1997 Half Yearly Results -
Jun 28, 1997 Accounts & Dividend -
Ex-Date Bonus Ratio Record Date
Bigul
01 Jul 2024

NEULAND LABORATORIES LTD. - 524558 - Update On Transfer Of Part Of Nanakramguda Property

 Update on transfer of part of Nanakramguda property
27 Jun 2024

Neuland Laboratories - Improved Products Mix To Drive Growth: DRChoksey

 The management also believes that improved business is likely over medium term with the ramp up in CMS and specialty.
Bigul
26 Jun 2024

NEULAND LABORATORIES LTD. - 524558 - Closure of Trading Window

 Closure of Trading Window
Bigul
21 Jun 2024

NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper advertisement regarding 40th Annual General Meeting to be held through video conference, record date and final dividend information
Bigul
21 Jun 2024

NEULAND LABORATORIES LTD. - 524558 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Issue of Letter of Confirmation in lieu of Share Certificate(s) reported lost / misplaced
Bigul
18 Jun 2024

NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation about Schedule of Analyst / Institutional Investor Meetings on June 24 & 25, 2024
Bigul
10 Jun 2024

NEULAND LABORATORIES LTD. - 524558 - Change In The Logo Of The Company

 Change in the logo of the Company
Bigul
03 Jun 2024

NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation about Schedule of Analyst / Institutional Investor Meetings on 11/06/2024
Bigul
03 Jun 2024

NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation about Schedule of Analyst / Institutional Investor Meetings on 07/06/2024
Bigul
03 Jun 2024

NEULAND LABORATORIES LTD. - 524558 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of Loss of Share Certificate(s)
See all News

FAQs

The latest market price of Neuland Laboratories Ltd. on NSE was Rs. 7702.00 as of today.

The opening share price of Neuland Laboratories Ltd. was Rs. 7647.00 as of today.

The 52-week high share price of Neuland Laboratories Ltd. was Rs. 8079.00.

The 52 week low share price of Neuland Laboratories Ltd. was Rs. 2786.10.

Neuland Laboratories Ltd. has a market cap of Rs. 9881.60 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Neuland Laboratories Ltd. is 0.40. Please refer to the Fundamentals section for further details.

The operating revenue for Neuland Laboratories Ltd. in the last FY was Rs.  1558.58 crore. Please refer to the Financials section for further details.

The Net Profit for Neuland Laboratories Ltd. in the last FY was Rs. 300.08 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Neuland Laboratories Ltd. was on 2023-07-11 for Rs. 10 per share. According to today’s share price, the dividend yield of Neuland Laboratories Ltd. stands at 0.10. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Neuland Laboratories Ltd..

Close

Let's Open Free Demat Account